Edgestream Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,636
| Closed | -$304K | – | 1124 |
|
|
2024
Q4 | $304K | Sell |
3,636
-50,993
| -93% | -$4.26M | 0.01% | 756 |
|
|
2024
Q3 | $4M | Buy |
+54,629
| New | +$4M | 0.18% | 187 |
|
|
2024
Q2 | – | Sell |
-18,137
| Closed | -$1.26M | – | 1078 |
|
|
2024
Q1 | $1.26M | Buy |
18,137
+4,707
| +35% | +$326K | 0.06% | 447 |
|
|
2023
Q4 | $962K | Sell |
13,430
-30,656
| -70% | -$2.2M | 0.07% | 450 |
|
|
2023
Q3 | $2.3M | Buy |
44,086
+19,980
| +83% | +$1.04M | 0.18% | 158 |
|
|
2023
Q2 | $1.53M | Buy |
+24,106
| New | +$1.53M | 0.14% | 257 |
|